JPWO2020130146A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020130146A5 JPWO2020130146A5 JP2020561551A JP2020561551A JPWO2020130146A5 JP WO2020130146 A5 JPWO2020130146 A5 JP WO2020130146A5 JP 2020561551 A JP2020561551 A JP 2020561551A JP 2020561551 A JP2020561551 A JP 2020561551A JP WO2020130146 A5 JPWO2020130146 A5 JP WO2020130146A5
- Authority
- JP
- Japan
- Prior art keywords
- muscle
- improving
- muscle quality
- agent according
- cystine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000003205 muscle Anatomy 0.000 claims 28
- 239000003795 chemical substances by application Substances 0.000 claims 22
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 16
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 claims 8
- 239000004471 Glycine Substances 0.000 claims 8
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims 8
- 229960003067 cystine Drugs 0.000 claims 8
- 229960000310 isoleucine Drugs 0.000 claims 8
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims 8
- 229960002449 glycine Drugs 0.000 claims 6
- 206010022489 Insulin Resistance Diseases 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 230000004898 mitochondrial function Effects 0.000 claims 2
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018240020 | 2018-12-21 | ||
| JP2018240020 | 2018-12-21 | ||
| PCT/JP2019/050188 WO2020130146A1 (ja) | 2018-12-21 | 2019-12-20 | 筋質向上剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2020130146A1 JPWO2020130146A1 (ja) | 2021-11-04 |
| JPWO2020130146A5 true JPWO2020130146A5 (https=) | 2022-12-28 |
| JP7548014B2 JP7548014B2 (ja) | 2024-09-10 |
Family
ID=71101355
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020561551A Active JP7548014B2 (ja) | 2018-12-21 | 2019-12-20 | 筋質向上剤 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20210308084A1 (https=) |
| EP (1) | EP3900718A4 (https=) |
| JP (1) | JP7548014B2 (https=) |
| WO (1) | WO2020130146A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GEP20237469B (en) * | 2020-11-10 | 2023-02-10 | Dzala Llc | Novel compositions for neutralizing toxic effects of hydrogen peroxide in living cells or tissues |
| US20240100006A1 (en) * | 2020-12-09 | 2024-03-28 | Societe Des Produits Nestle S.A. | Compositions and methods using at least one glycine or derivative thereof and at least one large neutral amino acid and/or cationic amino acid or precursor thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013175266A1 (en) * | 2012-05-21 | 2013-11-28 | Chemi Nutra Inc. | Method for increasing muscle mass and strength |
| US9820504B2 (en) * | 2013-03-08 | 2017-11-21 | Axiom Foods, Inc. | Rice protein supplement and methods of use thereof |
| WO2014138304A1 (en) | 2013-03-08 | 2014-09-12 | Axiom Foods, Inc., | Rice protein supplements |
| WO2014191856A1 (en) | 2013-05-31 | 2014-12-04 | Nestec S.A. | Methods for enhancement of muscle protein synthesis |
| WO2015133627A1 (ja) * | 2014-03-07 | 2015-09-11 | 味の素株式会社 | 虚弱予防剤 |
| JP6496599B2 (ja) * | 2014-06-13 | 2019-04-03 | 花王株式会社 | 筋タンパク質合成シグナル活性化剤 |
| WO2017159741A1 (ja) * | 2016-03-16 | 2017-09-21 | 味の素株式会社 | 行動体力向上剤 |
-
2019
- 2019-12-20 WO PCT/JP2019/050188 patent/WO2020130146A1/ja not_active Ceased
- 2019-12-20 EP EP19900986.1A patent/EP3900718A4/en active Pending
- 2019-12-20 JP JP2020561551A patent/JP7548014B2/ja active Active
-
2021
- 2021-06-16 US US17/349,207 patent/US20210308084A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014094951A5 (https=) | ||
| JP2019068829A5 (https=) | ||
| JPWO2020130146A5 (https=) | ||
| JP2015511635A5 (https=) | ||
| EP4342312A3 (en) | Tobacco composition | |
| JP2015131825A5 (https=) | ||
| JP2017532343A5 (https=) | ||
| JP2020517703A5 (https=) | ||
| JP2019520344A5 (https=) | ||
| JP2019515909A5 (https=) | ||
| JP2009521473A5 (https=) | ||
| JOP20200064B1 (ar) | تحضير صور جرعة صلبة تشتمل على أجسام مضادة بعمل طبقات من المحلول/ المعلق | |
| JP2021526021A5 (https=) | ||
| JP2018199643A5 (https=) | ||
| WO2014008374A3 (en) | Combination therapies comprising metformin salts and antihyperglycemia agents or antihyperlipidemia agents | |
| JP2008540506A5 (https=) | ||
| UA102547C2 (uk) | Тверда фармацевтична композиція | |
| JP2016526379A5 (https=) | ||
| CY1113943T1 (el) | Παρασκευασμα κατακρατησης 3-(2- διμεθυλαμινομεθυλο-κυκλοεξυλο) φαινολης | |
| JP2017529355A5 (https=) | ||
| JP2019218304A5 (https=) | ||
| WO2016003158A3 (ko) | DX2 단백질과 p14/ARF 단백질 간의 결합을 억제하는 신규 화합물 및 상기 화합물을 유효성분으로 함유하는 암질환 치료 또는 예방용 약학조성물 | |
| JPWO2019171843A5 (https=) | ||
| JP2019508507A5 (https=) | ||
| JPWO2019194130A5 (https=) |